Chronic Lower Back Pain Treatment Market Size, Share & COVID-19 Impact Analysis, By Drug Class (Non-steroidal Anti-Inflammatory Drugs, Antidepressants, Analgesic, Opioids, and Others), By Route of Administration (Oral, Topical, and Others), By Distribution Channel (Hospital Pharmacies and Retail & Online Pharmacies), and Regional Forecast, 2025-2032

Last Updated: June 02, 2025 | Format: PDF | Report ID: FBI100575

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Period	2019-2032
Base Year	2024
Estimated Year	2025
Forecast Period	2025-2032
Historical Period	2019-2023
Growth Rate	CAGR of 10.1% from 2025 to 2032
Unit	Value (USD billion)
Segmentation	By Drug Class Non-steroidal Anti-Inflammatory Drugs Antidepressants Analgesic Opioids Others
	By Route of Administration Oral Topical Others
	By Distribution Channel Hospital Pharmacies Retail & Online Pharmacies
	By Region North America (By Drug Class, By Route of Administration, By Distribution Channel, By Country/Sub-Region) U.S. Canada Europe (By Drug Class, By Route of Administration, By Distribution Channel, By Country/Sub-Region) U.K. Germany France Italy Spain Scandinavia Rest of Europe Asia Pacific (By Drug Class, By Route of Administration, By Distribution Channel, By Country/Sub-Region) China India Japan Australia Southeast Asia Rest of Asia Pacific Latin America (By Drug Class, By Route of Administration, By Distribution Channel, By Country/Sub-Region) Brazil Mexico Rest of Latin America Middle East & Africa (By Drug Class, By Route of Administration, By Distribution Channel, By Country/Sub-Region) GCC South Africa Rest of Middle East & Africa